Guillain-Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy

Clinical Rheumatology

Volumn 28, Issue SUPPL. 1, 2009, Pages

  Bouchra, Amine ^a   Benbouazza, Karima ^a   Hajjaj Hassouni, Najia ^a  

^a Hopital El Ayachi   (Morocco)

Author keywords

Anti TNF ; Guillain Barre; Infliximab; Spondylarthropathy; Ulcerative colitis

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; INFLIXIMAB;

ADULT; ANAMNESIS; ANKYLOSING SPONDYLITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE EXACERBATION; DOSE RESPONSE; ELECTROMYOGRAPHY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MUSCLE STRENGTH; NEUROPHYSIOLOGY; PARESTHESIA; PRIORITY JOURNAL; ULCERATIVE COLITIS; WEAKNESS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; COLITIS, ULCERATIVE; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MIDDLE AGED; SPONDYLARTHROPATHIES;

EID: 67349125158     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1154-7     Document Type: Article

References (15)

1. James SL, Irving PM, Gearry RB, Gibson PR (2008) Management of distal ulcerative colitis: Frequently asked questions analysis. Intern Med J 38:114-119
2. Chang-Hee S, Chang-Hee L et al (1998) Arthritis manifestations of inflammatory bowel disease. J Korean Med Sci 13:39-43
3. Braunand J, Sieper J (2004) Biological therapies in the spondyloarthritides - the current state. Rheumatology 43:1072-1084
4. Gondim FAA, Brannagan TH, Sander HW, Chin RL, Latov N (2005) Peripheral neuropathy in patients with inflammatory bowel disease. Brain 128(4):867-879
5. Okiyama R, Yamada M, Tamaki M, Orimo S, Arai M (1993) Mononeuropathy multiplex with ulcerative colitis. Intern Med 32(8):651-654
6. Sandborn WJ (2003) Strategies for targeting tumour necrosis factor in IBD. Best Pract Res Clin Gastroenterol 17(1):105-117
7. Konagaya Y, Konagaya M, Takayanagi T (1989) Chronic polyneuropathy and ulcerative colitis. Jpn J Med 28(1):72-74
8. Silburn S, McIvor E, Mc Entegart A, Wilson H (2008) Guillain-Barré syndrome in a patient receiving anti-tumour necrosis factor α for rheumatoid arthritis: A case report and discussion of literature. ARD 67:575-576
9. Stübgen J-P (2008) Tumor necrosis factor-α antagonists and neuropathy. Muscle Nerve 37(3):281-292
10. Shin I-SJ, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN (2006) Guillain-Barre and Miller Fisher syndromes occurring with tumor necrosis factor α antagonist therapy. Arthritis Rheum 54(5):1429-1434
11. Neven N, Vis M, Voskuyl AE, Wolbink GJ, Nurmohamed MT, Dijkmans BAC, Lems WF (2005) Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice. ARD 64:645-646
12. Slee M, Selan A, Donaghy M (2007) Multifocal motor neuropathy: The diagnostic spectrum and response to treatment. Neurology 69:1680-1687
13. Jarand J, Zochodne DW, Martin L, Voll C (2006) Neurological complications of infliximab. J Rheumatol 33:1018-1020
14. Richette P, Dieudé P, Damiano J (2004) Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis. J Rheumatol 31(10):2079-2081
15. Rodriguez-Escalera C, Belzunegui J (2005) Multifocal motor neuropathy with conduction block in a patient with rheumatoid arthritis on infliximab therapy. Rheumatology 44:132-133